© 2004 by BMJ Publishing Group & British Cardiac Society
CASE REPORT
Paradoxical increase of pulmonary vascular resistance during testing of inhaled iloprost
University of Cologne, Cologne, Germany
Correspondence to:
Correspondence to:
Dr med M Emmel
Josef Stelzmann Strasse 9,50924 Cologne, Germany; mathias.emmel{at}medizin.uni-koeln.de
The case of a 14 month old girl with primary pulmonary hypertension treated with domiciliary oxygen is described. After invasive evaluation and testing of nitric oxide with very good response, the testing was repeated to study the effect of inhaled iloprost on pulmonary vascular resistance (PVR). An unexpected and severe increase of PVR was observed, rising from 392 dynes·s·cm-5 with oxygen to a maximum of 1192 dynes·s·cm-5 with oxygen and iloprost. Underlying ventilatory and technical problems were excluded. While inhaled iloprost has been described to be highly effective in the treatment of primary pulmonary hypertension, the possibility of contrary "paradoxical" reactions in isolated patients is emphasised, with a dramatic increase of PVR and a possible adverse outcome.
Keywords: pulmonary hypertension; pulmonary vascular resistance; iloprost; inhalation; vasodilator
Abbreviations: mPAP, mean pulmonary artery pressure; mSAP, mean systemic artery pressure; PPH, primary pulmonary hypertension; PVR, pulmonary vascular resistance
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
